The FDA also approved Ozempic in early 2025 to treat kidney disease
Federal health authorities continue to flag significant clinical concerns, including immunogenicity risks and the theoretical potential to stimulate oncogenic (cancer) pathways
NH: Resources, Writing original draft
In Diverse Therapeutic Strategies Targeting TMAO, we curated the most pertinent preclinical and in vitro studies on TMAO, emphasizing findings associated with TMAO-induced cell death to deliver a thorough summary of its role in the development and progression of diseases along the gut-organ (lung, pancreas, heart, kidney, and brain) axis
Comparisons can only be made empirically
They are free from GMOs, preservatives, artificial colors, dairy, soy, eggs, nuts, gluten, and gelatin